High rate of autoimmune thyroiditis in bipolar disorder: Lack of association with lithium exposure

Biological Psychiatry

Volumn 51, Issue 4, 2002, Pages 305-311

  Kupka, Ralph W ^a,h   Nolen, Willem A ^a   Post, Robert M ^c   McElroy, Susan L ^d   Altshuler, Lori L ^e   Denicoff, Kirk D ^c   Frye, Mark A ^e   Keck Jr , Paul E ^d   Leverich, Gabriele S ^c   Rush, A John ^f   Suppes, Trisha ^f   Pollio, Chad ^g   Drexhage, Hemmo A ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF TEXAS AT DALLAS   (United States)

^g Stanley Foundation Data Coordinating Center   (United States)

^h Altrecht Inst for Mental Hlth Care   (Netherlands)

Author keywords

Bipolar disorder; Hypothyroidism; Lithium; Thyroid antibodies

Indexed keywords

AUTOANTIBODY; LITHIUM; THYROID HORMONE; THYROID PEROXIDASE ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EXPOSURE; FEMALE; GENDER; HASHIMOTO DISEASE; HORMONE SUBSTITUTION; HUMAN; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; MANIC DEPRESSIVE PSYCHOSIS; MENTAL PATIENT; MOOD; POPULATION; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; THYROID DISEASE; THYROTROPIN BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES; BIPOLAR DISORDER; COHORT STUDIES; FEMALE; HUMANS; LITHIUM; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; THYROIDITIS, AUTOIMMUNE; THYROTROPIN;

EID: 18344377668     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(01)01217-3     Document Type: Article

References (42)

1. Evaluation of thyroid function in patients with rapid-cycling and non-rapid-cycling bipolar disorder
2. Rapid cycling bipolar affective disorder. II. Treatment of refractory rapid cycling with high-dose levothyroxine: A preliminary study
3. Rapid cycling bipolar affective disorder. I. Association with grade I hypothyroidism
4. Six-year follow-up of thyroid function during lithium treatment
5. Ten-year follow-up of lithium patients with special reference to thyroid function
6. Autoimmune thyroiditis in manic-depressive patients treated with lithium
7. The effect of lithium treatment on thyroid function in patients with primary affective disorder
8. Thyroid abnormalities associated with rapid cycling bipolar illness
9. The autoimmune endocrinopathies
10. The presence of antithyroid antibodies in patients with affective and non-affective psychiatric disorders
11. Prevalence of antithyroid antibodies in mood disorders
12. Relationship of serum TSH concentration and antithyroid antibodies to diagnosis and DST response in psychiatric inpatients
13. Lithium and autoimmune thyroid disease
14. Psychoendocrinology of mood disorders: The hypothalamic-pituitary-thyroid axis
15. Autoantibody disturbances in affective disorders: A function of age and gender?
16. Thyroid function and bipolar affective disorder
17. Lithium-induced subclinical hypothyroidism: Review of the literature and guidelines for treatment
18. The prevalence of thyroid dysfunction in a population with borderline iodine deficiency
19. Prediction of post partum thyroid dysfunction: Can it be improved?
20. Grade II and grade III hypothyroidism in rapid-cycling bipolar patients
21. Iodine intake and the pattern of thyroid disorders: A comparative epidemiological study of thyroid abnormalities in the elderly in Iceland and in Jutland, Denmark
22. Lithium therapy and thyroid function: A long-term study
23. Effect of lithium carbonate therapy on thyroid immune status in manic depressive patients: A prospective study
24. Lithium and antithyroid antibodies
25. The Stanley foundation bipolar treatment outcome network: I. Longitudinal methodology
26. A prospective study of the effects of lithium on thyroid function and on the prevalence of antithyroid antibodies
27. Incidence of abnormal thyroid function in patients with low titers of thyroid microsomal antibodies
28. Thyroid disorders in the general population of Hisayama Japan, with special reference to prevalence and sex differences
29. The prevalence of affective disorder and in particular of a rapid cycling of bipolar disorder in patients with abnormal thyroid function tests
30. Anti-thyroid peroxidase antibody in patients with autoimmune thyroid disease: Possible identity with anti-microsomal antibody
31. Rapid cycling bipolar disorder: Lack of relation to hypothyroidism
32. Marginal hypothyroidism in mental illness: Preliminary assessments of prevalence and significance
33. Immune parameters in euthymic bipolar patients and normal volunteers
34. Thyroid peroxidase autoantibodies
35. Population survey of thyroid autoimmunity in Italy. Three year follow up
36. Serum thyroglobulin autoantibodies: Prevalence, influence on serum thyroglobulin measures, and prognostic significance in patients with differentiated thyroid carcinoma
37. The Stanley foundation bipolar treatment outcome network: II demographics and illness characteristics of the first 261 patients
38. The incidence of thyroid disorders in the community: A twenty-year follow-up of the Whickham Survey
39. Rapid cycling affective disorder: Contributing factors and treatment responses in 51 patients
40. The effect of lithium therapy on parameters thought to be involved in the development of autoimmune thyroid disease
41. Association of serum antithyroid antibodies with lymphocytic infiltration of the thyroid gland: Studies of seventy autopsied cases